Abstract
Acylhydrazide Schiff bases 1-27 were evaluated for their in vitro DPPH radical and superoxide anion scavenging activity. They showed a varying degree of DPPH radical scavenging activity with IC50 values between 31.25 - 473.59 µM. Compounds 8, 2, and 10 have IC50 values 31.25 ± 1.32, 34.40 ± 0.66, and 37.24 ± 0.4 µM, respectively. Standard npropylgallate showed an IC50 value 30.12 ± 0.27 µM. Acylhydrazides 1-27 exhibited in vitro superoxide anion scavenging activities with IC50 values in the range of 175.6 - 450.89 µM. Results demonstrated that acylhyrazides 8, 2, and 10 have DPPH scavenging activity, comparable to standard n-propyl gallate while acylhyrazides 1-27 were found to be less superoxide anion scavenging active than the standard n-propyl gallate (IC50 = 106.34 ± 1.6 µM).
Keywords: Acylhyrazide Schiff bases, DPPH scavenger, superoxide anion scavenger, antioxidant, chemotherapeutic agents, antifungal, antiproliferative properties, anticonvulsant, analgesic
Medicinal Chemistry
Title:Acylhydrazide Schiff Bases: DPPH Radical and Superoxide Anion Scavengers
Volume: 8 Issue: 4
Author(s): Khalid Mohammed Khan, Muhammad Taha, Farzana Naz, Salman Siddiqui, Sajjad Ali, Fazal Rahim, Shahnaz Perveen and M. Iqbal Choudhary
Affiliation:
Keywords: Acylhyrazide Schiff bases, DPPH scavenger, superoxide anion scavenger, antioxidant, chemotherapeutic agents, antifungal, antiproliferative properties, anticonvulsant, analgesic
Abstract: Acylhydrazide Schiff bases 1-27 were evaluated for their in vitro DPPH radical and superoxide anion scavenging activity. They showed a varying degree of DPPH radical scavenging activity with IC50 values between 31.25 - 473.59 µM. Compounds 8, 2, and 10 have IC50 values 31.25 ± 1.32, 34.40 ± 0.66, and 37.24 ± 0.4 µM, respectively. Standard npropylgallate showed an IC50 value 30.12 ± 0.27 µM. Acylhydrazides 1-27 exhibited in vitro superoxide anion scavenging activities with IC50 values in the range of 175.6 - 450.89 µM. Results demonstrated that acylhyrazides 8, 2, and 10 have DPPH scavenging activity, comparable to standard n-propyl gallate while acylhyrazides 1-27 were found to be less superoxide anion scavenging active than the standard n-propyl gallate (IC50 = 106.34 ± 1.6 µM).
Export Options
About this article
Cite this article as:
Mohammed Khan Khalid, Taha Muhammad, Naz Farzana, Siddiqui Salman, Ali Sajjad, Rahim Fazal, Perveen Shahnaz and Iqbal Choudhary M., Acylhydrazide Schiff Bases: DPPH Radical and Superoxide Anion Scavengers, Medicinal Chemistry 2012; 8 (4) . https://dx.doi.org/10.2174/157340612801216111
DOI https://dx.doi.org/10.2174/157340612801216111 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Stem Cells: A Golden Therapy for Diabetic Wounds
Current Diabetes Reviews Nearly Half of Uncontrolled Hypertensive Patients could be Controlled by High-dose Titration of Amlodipine in the Clinical Setting: The ACHIEVE Study
Current Hypertension Reviews Electrostimulators and Muscle Fatigue: A Patent Review
Recent Patents on Mechanical Engineering Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study
Current Vascular Pharmacology Passive Targeting of Cyclophosphamide-Loaded Carbonate Apatite Nanoparticles to Liver Impedes Breast Tumor Growth in a Syngeneic Model
Current Pharmaceutical Design Adenosine in the Central Nervous System: Effects on Neurotransmission and Neuroprotection
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Inflammation and Coronary Artery Disease
Current Vascular Pharmacology The Therapeutic Role of Xenobiotic Nuclear Receptors Against Metabolic Syndrome
Current Drug Metabolism A Possible Placental Factor for Preeclampsia: sFlt-1
Current Medicinal Chemistry SAGE Application in the Study of Diabetes
Current Pharmaceutical Biotechnology Adult Neural Stem Cells: Response to Stroke Injury and Potential for Therapeutic Applications
Current Stem Cell Research & Therapy Preface
Current Vascular Pharmacology The Possible Therapeutic Actions of Peroxisome Proliferator-Activated Receptor α(PPARα) Agonists,PPARγ Agonists,3-Hydroxy-3- Methylglutaryl Coenzyme A (HMG-CoA)Reductase Inhibitors,Angiotensin Converting Enzyme (ACE)Inhibitors and Calcium (Ca)-Antagonists on Vascular Endothelial Cells
Current Drug Targets - Cardiovascular & Hematological Disorders Mitochondrion-Specific Antioxidants as Drug Treatments for Alzheimer Disease
CNS & Neurological Disorders - Drug Targets How to Find Candidate Drug-targets for Antiepileptogenic Therapy?
Current Neuropharmacology New Therapeutic Aspects of Inflammatory Cardiomyopathy
Current Pharmaceutical Design Adult Neurogenesis in the Hypothalamus: Evidence, Functions and Implications
CNS & Neurological Disorders - Drug Targets Structural Insight on GPR119 Agonist as Potential Therapy for Type II Diabetes: A Comprehensive Review
Mini-Reviews in Medicinal Chemistry Treatment Strategies Against Diabetic Foot Ulcer: Success so Far and the Road Ahead
Current Diabetes Reviews Beneficial Morphofunctional Changes Promoted by Sildenafil in Resistance Vessels in the Angiotensin II-Induced Hypertension Model
Current Pharmaceutical Biotechnology